| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
|
Circulation
|
2008
|
8.94
|
|
2
|
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2008
|
6.78
|
|
3
|
Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.
|
JAMA
|
2009
|
4.29
|
|
4
|
Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study.
|
Circulation
|
2007
|
3.57
|
|
5
|
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
|
J Am Coll Cardiol
|
2012
|
3.25
|
|
6
|
Familial atrial fibrillation is a genetically heterogeneous disorder.
|
J Am Coll Cardiol
|
2003
|
3.09
|
|
7
|
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary.
|
Heart Rhythm
|
2008
|
2.75
|
|
8
|
Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation.
|
N Engl J Med
|
2003
|
2.68
|
|
9
|
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
|
Circulation
|
2012
|
2.39
|
|
10
|
Syncope while driving: clinical characteristics, causes, and prognosis.
|
Circulation
|
2009
|
2.30
|
|
11
|
Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction.
|
JAMA
|
2012
|
2.25
|
|
12
|
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2012
|
2.23
|
|
13
|
Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope management.
|
Circulation
|
2004
|
2.04
|
|
14
|
Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices.
|
Heart Rhythm
|
2004
|
2.01
|
|
15
|
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.
|
Heart Rhythm
|
2008
|
1.72
|
|
16
|
The natural history of lone atrial flutter.
|
Ann Intern Med
|
2004
|
1.68
|
|
17
|
Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.
|
Am J Cardiol
|
2005
|
1.65
|
|
18
|
Myocardium of the superior vena cava, coronary sinus, vein of Marshall, and the pulmonary vein ostia: gross anatomic studies in 620 hearts.
|
J Cardiovasc Electrophysiol
|
2012
|
1.55
|
|
19
|
Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
|
Heart Rhythm
|
2010
|
1.52
|
|
20
|
Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
|
J Cardiovasc Electrophysiol
|
2004
|
1.48
|
|
21
|
Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance.
|
Heart Rhythm
|
2009
|
1.46
|
|
22
|
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Thorac Cardiovasc Surg
|
2012
|
1.45
|
|
23
|
Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy.
|
J Cardiovasc Electrophysiol
|
2007
|
1.44
|
|
24
|
Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly.
|
Eur Heart J
|
2006
|
1.42
|
|
25
|
Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias.
|
J Cardiovasc Electrophysiol
|
2008
|
1.40
|
|
26
|
The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011.
|
Heart Rhythm
|
2013
|
1.39
|
|
27
|
Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures.
|
Heart Rhythm
|
2008
|
1.38
|
|
28
|
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected].
|
Circulation
|
2012
|
1.37
|
|
29
|
P wave signal-averaged electrocardiography to identify risk for atrial fibrillation.
|
Pacing Clin Electrophysiol
|
2002
|
1.37
|
|
30
|
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
J Am Coll Cardiol
|
2015
|
1.26
|
|
31
|
Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden, duration, coupling interval, morphology and site of origin of PVCs.
|
J Cardiovasc Electrophysiol
|
2011
|
1.22
|
|
32
|
Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organizations (COPE).
|
Heart Rhythm
|
2006
|
1.20
|
|
33
|
Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation.
|
J Interv Card Electrophysiol
|
2008
|
1.18
|
|
34
|
Anatomical correlates relevant to ablation above the semilunar valves for the cardiac electrophysiologist: a study of 603 hearts.
|
J Interv Card Electrophysiol
|
2010
|
1.17
|
|
35
|
Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).
|
Heart Rhythm
|
2009
|
1.12
|
|
36
|
Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence.
|
J Cardiovasc Electrophysiol
|
2010
|
1.12
|
|
37
|
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Heart Rhythm
|
2012
|
1.11
|
|
38
|
Mechanisms and utility of discrete great arterial potentials in the ablation of outflow tract ventricular arrhythmias.
|
Circ Arrhythm Electrophysiol
|
2008
|
1.11
|
|
39
|
Electrocardiography cannot reliably differentiate transient left ventricular apical ballooning syndrome from anterior ST-segment elevation myocardial infarction.
|
J Electrocardiol
|
2006
|
1.05
|
|
40
|
Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure.
|
Am Heart J
|
2013
|
1.03
|
|
41
|
Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function.
|
Circ Arrhythm Electrophysiol
|
2011
|
1.01
|
|
42
|
Noncontact mapping to guide ablation of right ventricular outflow tract tachycardia.
|
J Am Coll Cardiol
|
2002
|
0.96
|
|
43
|
QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy.
|
JAMA
|
2013
|
0.96
|
|
44
|
Effect of atrial fibrillation pattern on survival in a community-based cohort.
|
Am J Cardiol
|
2005
|
0.95
|
|
45
|
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
Heart Rhythm
|
2015
|
0.94
|
|
46
|
Relation of QRS duration on the surface 12-lead electrocardiogram with mortality in patients with known or suspected coronary artery disease.
|
Am J Cardiol
|
2005
|
0.91
|
|
47
|
Catheter ablation for atrial fibrillation in patients with obesity.
|
Circulation
|
2008
|
0.91
|
|
48
|
Electrophysiological anatomy of typical atrial flutter: the posterior boundary and causes for difficulty with ablation.
|
J Cardiovasc Electrophysiol
|
2009
|
0.91
|
|
49
|
Prognostic significance of exercise induced arrhythmias and echocardiographic variables in hypertrophic cardiomyopathy.
|
Am J Cardiol
|
2007
|
0.90
|
|
50
|
Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death.
|
Am Heart J
|
2007
|
0.90
|
|
51
|
Risk factor implications of incidentally discovered uncomplicated bundle branch block.
|
Mayo Clin Proc
|
2005
|
0.90
|
|
52
|
Malignant arrhythmia in apical ballooning syndrome: risk factors and outcomes.
|
Indian Pacing Electrophysiol J
|
2008
|
0.90
|
|
53
|
Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
0.89
|
|
54
|
Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead.
|
J Cardiovasc Electrophysiol
|
2010
|
0.89
|
|
55
|
Long-term subjective memory function in ventricular fibrillation out-of-hospital cardiac arrest survivors resuscitated by early defibrillation.
|
Resuscitation
|
2004
|
0.88
|
|
56
|
Do abandoned leads pose risk to implantable cardioverter-defibrillator patients?
|
Heart Rhythm
|
2008
|
0.88
|
|
57
|
Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank.
|
Am Heart J
|
2010
|
0.86
|
|
58
|
Use of advanced mapping systems to guide ablation in complex cases: experience with noncontact mapping and electroanatomic mapping systems.
|
Pacing Clin Electrophysiol
|
2005
|
0.86
|
|
59
|
The relative lymphocyte count predicts death in patients receiving implantable cardioverter defibrillators.
|
Pacing Clin Electrophysiol
|
2002
|
0.86
|
|
60
|
Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank.
|
Am Heart J
|
2010
|
0.86
|
|
61
|
Prevalence and clinical outcomes of patients with multiple potential causes of syncope.
|
Mayo Clin Proc
|
2003
|
0.85
|
|
62
|
Predictors of unsuccessful electrical cardioversion in atrial fibrillation.
|
Am J Cardiol
|
2002
|
0.85
|
|
63
|
Sudden death after radiofrequency ablation of the atrioventricular node in patients with atrial fibrillation.
|
J Am Coll Cardiol
|
2002
|
0.84
|
|
64
|
Outcomes after ventricular fibrillation out-of-hospital cardiac arrest: expanding the chain of survival.
|
Mayo Clin Proc
|
2005
|
0.84
|
|
65
|
Relevance of endocavitary structures in ablation procedures for ventricular tachycardia.
|
J Cardiovasc Electrophysiol
|
2009
|
0.84
|
|
66
|
Age- and sex-related atrial electrophysiologic and structural changes.
|
Am J Cardiol
|
2004
|
0.84
|
|
67
|
Association of uncomplicated electrocardiographic conduction blocks with subsequent cardiac morbidity in a community-based population (Olmsted County, Minnesota).
|
Am J Cardiol
|
2008
|
0.84
|
|
68
|
Significant effects of atrioventricular node ablation and pacemaker implantation on left ventricular function and long-term survival in patients with atrial fibrillation and left ventricular dysfunction.
|
Am J Cardiol
|
2003
|
0.83
|
|
69
|
Grade 3 ischemia on the admission electrocardiogram predicts rapid progression of necrosis over time and less myocardial salvage by primary angioplasty.
|
J Electrocardiol
|
2005
|
0.82
|
|
70
|
Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
|
Ann Intern Med
|
2014
|
0.82
|
|
71
|
The effect of patient sex on recurrence of atrial fibrillation following successful direct current cardioversion.
|
Am Heart J
|
2006
|
0.82
|
|
72
|
Epicardial ablation: reducing the risks.
|
J Cardiovasc Electrophysiol
|
2006
|
0.81
|
|
73
|
Changes in heart rate variability in response to treatment with electroconvulsive therapy.
|
J ECT
|
2004
|
0.81
|
|
74
|
Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing?: an analysis of 107,096 patients from the National Cardiovascular Data Registry's ICD Registry.
|
J Am Coll Cardiol
|
2012
|
0.81
|
|
75
|
The prognostic significance of exercise-induced atrial arrhythmias.
|
J Am Coll Cardiol
|
2004
|
0.81
|
|
76
|
Comparative efficacy of monophasic and biphasic waveforms for transthoracic cardioversion of atrial fibrillation and atrial flutter.
|
Am Heart J
|
2005
|
0.81
|
|
77
|
Distinguishing ventricular arrhythmia originating from the right coronary cusp, peripulmonic valve area, and the right ventricular outflow tract: utility of lead I.
|
J Cardiovasc Electrophysiol
|
2014
|
0.81
|
|
78
|
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
Heart Rhythm
|
2015
|
0.81
|
|
79
|
Outcome of patients with newly diagnosed atrial fibrillation at the Mayo Clinic and residing in that area.
|
Am J Cardiol
|
2004
|
0.80
|
|
80
|
Outcomes and in-hospital treatment of out-of-hospital cardiac arrest patients resuscitated from ventricular fibrillation by early defibrillation.
|
Mayo Clin Proc
|
2004
|
0.80
|
|
81
|
Unintentional deactivation of implantable cardioverter-defibrillators in health care settings.
|
Mayo Clin Proc
|
2002
|
0.80
|
|
82
|
Prediction of short- and long-term outcomes by electrocardiography in survivors of out-of-hospital cardiac arrest.
|
Resuscitation
|
2004
|
0.80
|
|
83
|
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy.
|
Am Heart J
|
2007
|
0.80
|
|
84
|
Progressive isthmus delay during atrial flutter ablation: the critical importance of isthmus spanning electrodes for distinguishing pseudoblock from block.
|
Pacing Clin Electrophysiol
|
2002
|
0.79
|
|
85
|
Recurrence of atrial tachyarrhythmias in implantable cardioverter-defibrillator recipients.
|
Pacing Clin Electrophysiol
|
2005
|
0.79
|
|
86
|
Anatomy of the coronary sinus and epicardial coronary venous system in 620 hearts: an electrophysiology perspective.
|
J Cardiovasc Electrophysiol
|
2012
|
0.79
|
|
87
|
Temporal trends in quality of care among recipients of implantable cardioverter-defibrillators: insights from the National Cardiovascular Data Registry.
|
Circulation
|
2013
|
0.78
|
|
88
|
Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope.
|
Am J Cardiol
|
2003
|
0.78
|
|
89
|
A modified Anderson-Wilkins electrocardiographic acuteness score for anterior or inferior myocardial infarction.
|
Am Heart J
|
2003
|
0.78
|
|
90
|
Long-term prognosis of inducible ventricular flutter: not an innocent finding.
|
Am Heart J
|
2004
|
0.78
|
|
91
|
ST-segment elevation: defined by the company it keeps.
|
Mayo Clin Proc
|
2012
|
0.78
|
|
92
|
Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions.
|
Am J Cardiol
|
2004
|
0.77
|
|
93
|
Prospective, randomized comparison of two biphasic waveforms for the efficacy and safety of transthoracic biphasic cardioversion of atrial fibrillation.
|
Heart Rhythm
|
2005
|
0.77
|
|
94
|
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
J Am Coll Cardiol
|
2015
|
0.77
|
|
95
|
Score indices for predicting electrophysiologic outcomes in patients with unexplained syncope.
|
J Interv Card Electrophysiol
|
2005
|
0.76
|
|
96
|
Utilization of retrograde right bundle branch block to differentiate atrioventricular nodal from accessory pathway conduction.
|
J Cardiovasc Electrophysiol
|
2009
|
0.76
|
|
97
|
Ventricular-based pacing: one site fits all?
|
J Cardiovasc Electrophysiol
|
2003
|
0.76
|
|
98
|
Design and rationale of a retrospective clinical effectiveness study of aldosterone antagonist therapy in patients with heart failure.
|
Am Heart J
|
2012
|
0.76
|
|
99
|
Ablation of atrial fibrillation: are the lines drawn?
|
Heart Rhythm
|
2004
|
0.75
|
|
100
|
Publicly reporting implantable cardioverter defibrillator outcomes: grading the report card.
|
Circ Arrhythm Electrophysiol
|
2008
|
0.75
|
|
101
|
Prevention of thromboembolic stroke in patients undergoing catheter-based ablation for atrial fibrillation: has it been optimized?
|
J Cardiovasc Electrophysiol
|
2009
|
0.75
|
|
102
|
Parasympathetics and atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2005
|
0.75
|
|
103
|
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
Circulation
|
2017
|
0.75
|
|
104
|
Quality improvement in electrocardiogram recording and interpretation.
|
J Electrocardiol
|
2008
|
0.75
|
|
105
|
Discrepancies between the upper limit of vulnerability and defibrillation threshold: prevalence and clinical predictors.
|
J Cardiovasc Electrophysiol
|
2003
|
0.75
|
|
106
|
Lack of effect of ECT on Holter monitor recordings before and after treatment.
|
J ECT
|
2004
|
0.75
|
|
107
|
Noninvasive assessment of acute changes in atrial electrophysiology after cardioversion by signal-averaged P-wave electrocardiography.
|
Pacing Clin Electrophysiol
|
2005
|
0.75
|
|
108
|
Highlights of Heart Rhythm 2005, the Annual Scientific Sessions of the Heart Rhythm Society, May 4-7, 2005, New Orleans, Louisiana.
|
Heart Rhythm
|
2005
|
0.75
|
|
109
|
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
Circulation
|
2017
|
0.75
|